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ABSTRACT 
 
Vascular embolization is an important clinical procedure, frequently used to reduce the size of a tumor, to 
facilitate the removal of a tumor during surgery or to define a treatment of tumor malformation. In addition, 
imaging is an important component for the evaluation and care of patients undergoing vascular embolization. 
Nowadays, during the embolization procedure, the radiologist uses the Angiography or Fluoroscopy (X-Ray 
images) technique to estimate devascularization, since only pathological examinations are able to show the 
exact location of the blockade and microspheres. SPECT imaging is widely used in Brazil and provides images 
of superior quality to the mentioned techniques. Therefore, radioactive polymeric microspheres can be used as 
radioembolization agents for SPECT imaging. This technique can improve the resolution of images and, 
consequently, the embolization procedure efficacy of uterine fibroids for example, by allowing the track of 
particles distribution in the veins and tumor, the homogeneity of this distribution and the end of the 
embolization procedure. In this work, we evaluate the copolymerization of 4-vinylphenol and vinyl acetate as a 
synthesis route for a new radioembolization agent. GPC analysis results showed that this comonomer presence 
improved the molar mass distribution. In addition, bulk polymerization tests and kinetic studies showed that the 
selected comonomer retards the reaction time, but does not decrease the conversion percentage. Indeed, this 
result points out the necessity of a comonomer chemical modification to improve yield results. 
 
 
1. INTRODUCTION 
 
Vascular embolization is an important clinical procedure, frequently used to reduce the size 
of a tumor, to facilitate the removal of a tumor during surgery or to define a treatment of 
tumor malformation. This technique consists of injecting fine solid particles dispersed in an 
aqueous medium, with the aid of a catheter, into blood vessels located near to the tumor 
region. In this way, a blockade occurs and the nutrient supply is interrupted. Therefore, the 
tumor region tends to shrink and eventually die, allowing the tissue recovery after a period of 
time [1]. 
 
The embolization procedure uses biocompatible and nontoxic particles to obstruct blood 
vessels. Normally, the poly (vinyl acetate) (PVAc) microspheres are used as embolization 
agents. These particles are obtained through the suspension polymerization reaction where 
the vinyl acetate (VAc) is the monomer and the benzoyl peroxide, the initiator [2]. 
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Imaging is an important component for the evaluation and care of patients undergoing 
vascular embolization. Nowadays, during the embolization procedure, the radiologist uses the 
Angiography or Fluoroscopy (X-Ray images) technique to estimate devascularization, since 
only pathological examinations are able to show the exact location of the blockade and 
microspheres [3,4]. SPECT (Single Photon Emission Computed Tomography) imaging is 
widely used in Brazil and provides images of superior quality to the mentioned techniques 
[5,6]. Therefore, radioactive polymeric microspheres can be used as radioembolization agents 
for SPECT imaging. This imaging technique can improve the resolution of images and, 
consequently, the embolization procedure efficacy of uterine fibroids for example, by 
allowing the track of particles distribution in the veins and tumor, the homogeneity of this 
distribution and the end of the embolization procedure. 
 
Upon the insertion of the iodine 123 (123I) radioisotope into PVAc particles, a new embolic 
agent is obtained and the SPECT technique can be used. To attach this radioisotope on PVAc 
microspheres, the synthesis route proposed was to select a substance that must contain both a 
free unsaturated hydrocarbon chain for the polymerization and an aromatic ring to receive the 
iodine. Iodinated aromatic rings show the lowest grade of deiodination in vivo. The 
4-vinylphenol (4VP) exhibits these required characteristics (Figure 1). 
 
 
 
 
Figure 1:  4-vinylphenol molecular structure. 
 
 
In addition, the hydroxyl moiety is an activating group that enhances the possibility of the 
iodine atom entrance at the ortho position in the aromatic ring. The phenol group enables, for 
example, the radioiodination of peptides and proteins containing phenolic residues of tyrosine 
or polymer nanoparticles containing phenol [7,8]. Besides, 4VP naturally occurs in ciders, 
wines, foods and berries, for example, and is used as an additive or ingredient in the Food 
Industry [9]. This work presents the polymerization exploratory studies between VAc and 
4VP to result in a new copolymer for radioiodination, the poly 
(vinyl acetate-co-4-vinyl phenol), signed as P(VAc-co-4VF). In this step, bulk polymerization 
tests and the kinetic study were performed to verify the possibility of copolymerization and 
the polymer behavior. Moreover, gel permeation chromatography (GPC) analysis was 
performed to characterize the copolymer molar mass distribution. The procedures herein 
described were based on the ones reported in the literature [10]. 
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2. MATERIALS AND METHODS 
 
 
2.1.  Reagents and Equipments 
 
Benzoyl peroxide (BPO), VAc and tetrahydrofuran (THF) substances were analytical grades 
and purchased from VETEC. The 4VP 10% in propylene glycol solution was purchased from 
Sigma. GPC equipment was a Viscotek, model GPC Max, equipped with three Shodex 
columns (two KF-804L and one KF-805L) and refractive detector Viscotek VE3580. 
2.2.  Bulk Polymerization 
 
BPO was selected as initiator for the free-radical polymerization involving the VAc and 4VP 
monomers. For each test tube, VAc and BPO were mixed until dissolving the initiator. 
Thereafter, 4VP was added. Table 1 shows the reagents proportions used for the reaction 
mixture (4 g). The test tubes were immersed in an ethylene glycol bath at 80 oC for 120 min. 
Both visual inspection and tube inclination were used to evaluate viscosity variations. 
 
Table 1:  Bulk polymerization tests  
 
Test tube   1a 2 3 
BPO  (% (m/m)) 1 1 1 
VAc   (% (m/m)) 99 98 94 
4VP   (% (m/m)) 0 1 5 
          a.  Blank. 
2.2.1.  4VP content study 
 
Further, new bulk polymerization tests were performed to define the content of 4VP should 
be present in the final copolymer. Table 2 shows the new experiments performed. 
 
Table 2:  New batch of bulk polymerization tests 
 
Test tube 1 2 3 4 5 6  7b 
BPO  (% (m/m)) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
VAc   (% (m/m)) 98.90 98.85 98.80 98.75 98.50 98.00 99.00 
4VP   (% (m/m)) 0.10 0.15 0.20 0.25 0.50 1.00 0.00 
    b.  Blank. 
2.3.  GPC Analysis 
 
Samples from the new batch of bulk polymerization tests were analyzed according to the 
following procedure: the samples (6.00 mg) were dissolved in THF (3 mL). This polymer 
solution was stirred for 24 h and filtered using a PTFE membrane with 0.20 μm pore 
diameter. Then, the solution (200 μL) was injected into the apparatus at 40 °C. Calibrations 
were performed using polystyrene standards ranging from 8 x 102 to 1.8 x 108 Da. 
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2.4.  Kinetic Investigation 
 
First, ten test tubes were weighed individually. Thereafter, a stock solution (44 ml) containing 
VAc (98.5% (m/m)), BPO (1% (m/m)) and 4VP (0.5% (m/m)) was prepared. An aliquot of 
this solution (4 mL) was dispensed into each test tube, which was weighed again. The tubes 
were inserted into the reaction bath at 80 oC. At the desired time, each tube was removed 
from the bath, dried and immersed in an ice bath. After a week in a vacuum oven (60 oC, 
400 mm Hg), the tubes were weighed every two days, within five consecutive days, which 
was sufficient for the weighed variations to be in the third decimal place. Finally, the 
conversion calculations were performed. 
 
 
3. RESULTS AND DISCUSSION 
 
3.1.  Bulk Polymerization Tests 
 
In the homopolymerization of VAc (blank), it was observed that the solution viscosity 
increased, while it remained unchanged in the other tubes. This result indicates that no 
polymerization occurs between VAc and 4VP at 1 and 5% (m/m) content. Even after a week, 
no changes were observed in the material. Therefore, the comonomer content was decreased 
from 0.10 to 1.00% (m/m) (Table 2). Figure 2 displays the solutions aspects with this new 
content. 
 
          
(a) 
 
          
(b) 
 
Figure 2:  Visual aspect of the materials before (a) and after (b) the reaction with the 
new range of 4VP content. 
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In this new batch of experiments, the blank (tube 7) and the test tubes from 1 to 5 showed an 
increase of viscosity, indicating that this range of comonomer allows copolymerization. As 
expected, the test tube 6 (1% (m/m) of 4VP) viscosity remained unchanged. 
3.2.  Molar Mass Distribution 
 
GPC analysis results characterized the difference in the copolymer molar mass distribution 
related to the 4VP content. The measured parameters in this analysis were the average 
molecular weight number (Mn), the average molecular weight (Mw) and the polydispersity 
index (PI) (Table 3). 
 
Table 3: Molar mass distributionc (PI = Mw/Mn) 
 
Test tube 1 2 3 4 5 7 
4VP (% (m/m)) 0.10 0.15 0.20 0.25 0.50 0.00 
Mn 18,945 28,410 17,373 17,950 20,953 17,989 
Mw 36,206 70,433 51,535 40,064 51,117 49,305 
PI 1.9 2.5 3.0 2.2 2.4 2.7 
c.  Both Mn and Mw were expressed in Dalton (Da). The analysis run for the test tube 6 was 
not performed. 
 
As observed in Table 3, the lowest Mn value obtained (17.373 Da) was for the copolymer 
containing 0.20% (m/m) of 4VP and the highest (28.410 Da), to 0.15% (m/m) of this 
comonomer. Similarly, for this comonomer, the lowest Mw value obtained (36.206 Da) was 
for the 0.10% (m/m) content and the highest one (70.433 Da), to 0.15% (m/m). 
 
In addition, the distributions were between the wide (IP > 3) and narrow (IP < 2) bands, 
indicating that the different percentages of 4VP cause a variation in the molar mass 
distribution of the copolymer obtained. Another effect observed due to the presence of 4VP 
was the decrease of the copolymer PI value, compared with the PVAc polymer, i.e., we can 
infer that the PVAc-co-4VP copolymer results in more homogeneous mass distributions than 
the PVAc polymer. The exception was for 4VP at 0.20% (m/m), where this parameter is 
higher. 
 
According to these results, any percentage ranging from 0.10 to 0.50 % (m/m) of 4VP could 
be used for subsequent studies. However, small amounts of 4VP could result in low yields of 
iodination. Hence, 0.50% (m/m) of 4VP was selected since it is the highest percentage that 
resulted in copolymerization. 
3.3.  Kinetic and Maximum Conversion 
 
Once the content of 4VP was defined, the reaction time in which the maximum 
polymerization conversion occurs must also be known. In general, the conversion of PVAc 
reaches 90 % in less than 120 min. However, in the presence of 4VP, the conversion is 
retarded until 90 min (Figure 3), showing an abrupt and significant increase after this time. 
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Figure 3:  Conversion study curve of the P(VAc-co-4VP) (98.50-0.50 % (m/m)). 
 
 
With 120 min of reaction, the conversion approaches 90% and varies smoothly around this 
percentage value. Therefore, this behavior suggests that 4VP can act as a retarder for the 
polymerization. 
 
 
4. CONCLUSIONS 
 
The 4VP compound showed to be an interesting monomer to form a copolymer with VAc. In 
low content, this monomer allows polymerization with 4VP, its presence does not cause 
significant variations on the molar mass distribution, and it acts as a retarder for the 
polymerization. However, these results pointed that further improvements are necessary. 
Firstly, an Infrared analysis could be performed to evaluate the presence of phenol in the 
copolymer. Being this result positive, a slight modification in the phenol moiety should be 
made both to preserve the vinyl unsaturated chain for the copolymerization reaction and to 
maintain the aromatic ring activated for the consequent iodination. Besides, this modification 
can improve the conversion to 100 %. In this case, the presence of a methoxy group instead 
of the phenol one seems a good alternative. This work represents the first step to reach the 
radioiodinated microspheres. 
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